Workflow
New Wave Announces Investment in Cartwheel Robotics, an Advanced Robotics Company Seeking to Build Humanoids for Humans
Globenewswire· 2025-06-13 19:30
Vancouver, BC, June 13, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (“New Wave” or the “Company”) (CSE:NWAI, FWB:0XM0, OTCPK:TRMNF) is pleased to announce that it has made a strategic investment of US$150,000 into Cartwheel Robotics Inc. (“Cartwheel Robotics”). Founded in 2021, Cartwheel Robotics develops and builds advanced robotics products and provides engineering services to businesses looking to solve complex problems. Cartwheel Robotics’ interdisciplinary team has experience working on some of th ...
Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split
Globenewswire· 2025-06-13 19:30
BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that it will implement a 1-for-20 reverse stock split of its issued and outstanding shares of common stock ("Reverse Stock Split"), effective at 5:00 p.m. Eastern Time on June 16, 2025. The Reverse Stock Split was approved by the Company's stockholders at the Company's Annual ...
Advanced Flower Capital Announces Dividend for the Second Quarter 2025
Globenewswire· 2025-06-13 19:30
WEST PALM BEACH, Fla., June 13, 2025 (GLOBE NEWSWIRE) -- Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC” or the “Company”) today announced its dividend for the quarter ending June 30, 2025. The Board of Directors of AFC declared a quarterly dividend of $0.15 per outstanding share of common stock for the quarter ending June 30, 2025. The dividend is payable on July 15, 2025 to the common stockholders of record on June 30, 2025. The Board of Directors evaluates the Company’s Distributable Earnings (as defi ...
Chart Industries to Present at J.P. Morgan Energy, Power, Renewables & Mining Conference
Globenewswire· 2025-06-13 19:30
ATLANTA, June 13, 2025 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a global leader in energy and industrial gas solutions, will present at the J.P. Morgan Energy, Power, Renewables & Mining Conference in New York. Jill Evanko, President and Chief Executive Officer will participate in a fireside discussion on Tuesday, June 24th, and a webcast is scheduled for 10:55 a.m. ET. A live audio webcast will be available on the company’s website at: Chart Industries, Inc. | News and Events - Ev ...
Melco Announces Appointment of New Independent Non-Executive Director
Globenewswire· 2025-06-13 19:11
MACAU, June 13, 2025 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment Limited (Nasdaq: MLCO) (“Melco” or the “Company”), a developer, owner, and operator of integrated resort facilities in Asia and Europe, today announced the appointment of Mr. John Peter Ben Wang as an independent non-executive director of the Company, effective as of June 13, 2025. In addition, Mr. Wang has been appointed as the chairman of the Company’s audit and risk committee and a member of each of the Company’s compensation committe ...
Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress
Globenewswire· 2025-06-13 19:00
– ARV-393 demonstrated significant single-agent activity in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (also known as AITL) and transformed follicular lymphoma – – In combination with small molecule inhibitors, ARV-393 demonstrated enhanced tumor growth inhibition, including tumor regressions, in models of aggressive diffuse large B-cell lymphoma (DLBCL) – NEW HAVEN, Conn., June 13, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company ...
ORLADEYO® (berotralstat) Approved in Colombia
Globenewswire· 2025-06-13 19:00
RESEARCH TRIANGLE PARK, N.C., June 13, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the National Institute of Drug and Food Surveillance (INVIMA) in Colombia has granted approval for oral, once-daily ORLADEYO® (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks in adults and pediatric patients 12 years of age or older. “Today’s announcement marks another important step toward bringing ORLADEYO to people living with HAE who are in need of n ...
Fractyl Health to Present New Preclinical Data from its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific Sessions
Globenewswire· 2025-06-13 19:00
BURLINGTON, Mass., June 13, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D), today announced it will present a poster of new preclinical data from its Rejuva Smart GLP-1 pancreatic gene therapy platform at the American Diabetes Association’s (ADA) 85th Scientific Sessions being held June 20-23, 2025, in Chicago, Illinois. Poster Presentation Detail ...
Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Supporting Differentiated Profile in Sickle Cell Disease (SCD) at European Hematology Association (EHA) 2025 Congress
Globenewswire· 2025-06-13 19:00
Updated Data from 17 Patients Consistent with Previously Presented Data; All Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to <40%, and Resolution of Anemia Patients Required a Median of One Mobilization Cycle and Experienced Rapid Neutrophil and Platelet Engraftment Safety Profile Remained Consistent with Busulfan Conditioning, Autologous Hematopoietic Stem Cell Transplantation and Underlying SCD Enrollment Complete in Both Adult and Adolescent C ...
AYR Provides Update on Delay of Q1 2025 Interim Financial Filings
Globenewswire· 2025-06-13 19:00
MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces that it has not completed the filing of its interim financial statements, management’s discussion and analysis, and related CEO and CFO certificates for the three-month period ended March 31, 2025 (collectively, the “Interim Filings”) by the previously anticipated date of June 13, 2025.‎ As previously disclosed, the dela ...